Chemoprevention of Cancer
Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials
The management of cancer pain
Open Innovation Strategies
SGLT2 inhibition — a novel strategy for diabetes treatment
Innovation, Innovation Strategy, and Strategic Innovation
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial
Strategy and innovation
Innovation Strategy Approach
Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial